DC-based cancer vaccines: lessons from clinical trials.
Brody
J D
JD
Department of Pathology, Stanford University School of Medicine, CA, Stanford, USA.
Engleman
E G
EG
D000276:Adjuvants, Immunologic; D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology*; D019496:Cancer Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000276:immunology; D003713:Dendritic Cells / Q000276:immunology* / Q000637:transplantation*; D018572:Disease-Free Survival; D006801:Humans; D051379:Mice; D009364:Neoplasm Recurrence, Local; D009369:Neoplasms / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014611:Vaccination
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D016207:Cytokines